Validation of the Utility of Rare Disease Intelligence Platform

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
CataractArtificial Intelligence
Interventions
DEVICE

CC-Cruiser

An artificial intelligence to make comprehensive evaluation and treatment decision of congenital cataracts

Trial Locations (4)

510060

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

510080

Department of Ophthalmology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

510405

Department of Ophthalmology, First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou

511518

Department of Ophthalmology, Qingyuan People's Hospital, Qingyuan

All Listed Sponsors
collaborator

Ministry of Health, China

OTHER_GOV

collaborator

Xidian University

OTHER

lead

Sun Yat-sen University

OTHER

NCT02748044 - Validation of the Utility of Rare Disease Intelligence Platform | Biotech Hunter | Biotech Hunter